Featured Research

from universities, journals, and other organizations

University Of Illinois At Chicago Study Identifies Possible Predictor Of Tamoxifen Resistance

Date:
May 9, 2003
Source:
University Of Illinois At Chicago
Summary:
A discovery from the University of Illinois at Chicago College of Pharmacy may make it possible to anticipate which breast cancer patients will respond to tamoxifen and to devise a more appropriate therapy for those who do not.

A discovery from the University of Illinois at Chicago College of Pharmacy may make it possible to anticipate which breast cancer patients will respond to tamoxifen and to devise a more appropriate therapy for those who do not.

Tamoxifen has been used for more than 25 years to treat patients with certain types of breast cancer. But the drug is not effective for all patients, and until now, doctors and researchers have been unable to predict who would benefit and why.

In an article in the current issue of the British Journal of Cancer, Debra Tonetti, assistant professor of biopharmaceutical sciences in the UIC College of Pharmacy, reports the results of a study that identifies a possible predictor of tamoxifen resistance.

Tamoxifen works by blocking the effect of estrogen, which promotes the growth of breast cancer cells containing the estrogen receptor. However, in a retrospective study, Tonetti found that patients whose disease recurred had high levels of an enzyme called protein kinase C alpha, whereas patients who remained disease-free for at least five years had very low levels of PKC-alpha or none at all.

"Overproduction of PKC-alpha may be used to predict who will not respond to tamoxifen," Tonetti said. "In addition, we found that in mice, tumors that overproduce PKC-alpha completely regress with estrogen treatment."

These findings, her paper states, "may have important therapeutic applications in the management of breast cancer patients."

The initial study used archival biopsied tissue from 30 patients. Tonetti is now expanding her study, funded in part by the National Cancer Institute, and will use tissue from several hundred patients matched by age and disease stage to substantiate the preliminary findings. Upon completion of the entire study, in about 18 months, she hopes to start clinical trials.

"Cancer recurrence is a real problem," she said. "Finding more effective strategies for treating it would be very helpful."

For more information on the UIC College of Pharmacy, visit http://www.uic.edu/pharmacy.


Story Source:

The above story is based on materials provided by University Of Illinois At Chicago. Note: Materials may be edited for content and length.


Cite This Page:

University Of Illinois At Chicago. "University Of Illinois At Chicago Study Identifies Possible Predictor Of Tamoxifen Resistance." ScienceDaily. ScienceDaily, 9 May 2003. <www.sciencedaily.com/releases/2003/05/030509084441.htm>.
University Of Illinois At Chicago. (2003, May 9). University Of Illinois At Chicago Study Identifies Possible Predictor Of Tamoxifen Resistance. ScienceDaily. Retrieved April 17, 2014 from www.sciencedaily.com/releases/2003/05/030509084441.htm
University Of Illinois At Chicago. "University Of Illinois At Chicago Study Identifies Possible Predictor Of Tamoxifen Resistance." ScienceDaily. www.sciencedaily.com/releases/2003/05/030509084441.htm (accessed April 17, 2014).

Share This



More Health & Medicine News

Thursday, April 17, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Could Even Casual Marijuana Use Alter Your Brain?

Could Even Casual Marijuana Use Alter Your Brain?

Newsy (Apr. 16, 2014) A new study conducted by researchers at Northwestern and Harvard suggests even casual marijuana use can alter your brain. Video provided by Newsy
Powered by NewsLook.com
Thousands Of Vials Of SARS Virus Go Missing

Thousands Of Vials Of SARS Virus Go Missing

Newsy (Apr. 16, 2014) A research institute in Paris somehow misplaced more than 2,000 vials of the deadly SARS virus. Video provided by Newsy
Powered by NewsLook.com
Formerly Conjoined Twins Released From Dallas Hospital

Formerly Conjoined Twins Released From Dallas Hospital

Newsy (Apr. 16, 2014) Conjoined twins Emmett and Owen Ezell were separated by doctors in August. Now, nearly nine months later, they're being released from the hospital. Video provided by Newsy
Powered by NewsLook.com
Ebola Outbreak Now Linked To 121 Deaths

Ebola Outbreak Now Linked To 121 Deaths

Newsy (Apr. 15, 2014) The ebola virus outbreak in West Africa is now linked to 121 deaths. Health officials fear the virus will continue to spread in urban areas. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins